PIM1 (Provirus Integration Site For Moloney Murine Leukemia Virus) as a Novel Biomarker and Therapeutic Target in Pulmonary Arterial Hypertension: Another Evidence for Cancer Theory.
PIM1 (Provirus Integration Site For Moloney Murine Leukemia Virus) as a Novel Biomarker and Therapeutic Target in Pulmonary Arterial Hypertension: Another Evidence for Cancer Theory.
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):500-502
Authors: Satoh K, Kikuchi N, Shimokawa H
PMID: 32101474 [PubMed - in process]
Source: Arteriosclerosis, Thrombosis and Vascular Biology - Category: Cardiology Authors: Satoh K, Kikuchi N, Shimokawa H Tags: Arterioscler Thromb Vasc Biol Source Type: research
More News: Arteriosclerosis | Biology | Cancer | Cancer & Oncology | Cardiology | Hypertension | Leukemia | Pulmonary Thromboembolism | Thrombosis